Suchergebnisse - (Subject:"Adalimumab")

PubPharm (11.428)

1

Synergistic promotion of transient transgene expression in CHO cells by PDI/XBP-1s co-transfection and mild hypothermia

enthalten in: Bioprocess and biosystems engineering | 2024

von Zhang, X. | Wang, Y. | Yi, D. | +6

2

Clonal T lymphocytosis resolution after adalimumab discontinuation

enthalten in: Medicina clinica | 2024

von Alonso Trillo, R. | García Vela, J.

3

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Verstockt, B. | Pivorunas, V. | Al Mahi, N. | +10

4

Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy

enthalten in: Journal of Crohn's & colitis | 2024

von Wieringa, J. | Kruizinga, M. | Driessen, G. | +2

5

Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA) : does duration matter?

enthalten in: Clinical rheumatology | 2024

von Teh, K. | Das, L. | Book, Y. | +3

6

Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis

enthalten in: Turkish journal of ophthalmology | 2024

von Değirmenci, M. | Yalçındağ, F.

7

The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis : a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

enthalten in: The British journal of dermatology | 2024

von Alabas, O. | Mason, K. | Yiu, Z. | +46

CommentIn: Br J Dermatol. 2024 Jan 04;:. - PMID 38174815

8

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa : a Danish nationwide cohort study

enthalten in: The British journal of dermatology | 2024

von Ring, H. | Thorsen, J. | Kirby, B. | +10

9

mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

enthalten in: Journal of autoimmunity | 2024

von van den Dijssel, J. | Duurland, M. | Konijn, V. | +77

10

Adalimumab as treatment for neurosarcoidosis : A case series

enthalten in: Journal of the neurological sciences | 2024

von Shen, J. | Sugita, M. | Linares-Lopez, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1143]